Rani Therapeutics Holdings Amends Certificate of Incorporation
Rani Therapeutics Holdings, Inc. has amended its Certificate of Incorporation following approval from its board and majority shareholders. The changes comply with governing documents and Delaware law. The original filing is available via EDGAR, the SEC's system. This announcement was generated by Public Technologies using AI and is for informational purposes only.
Rani Therapeutics Holdings, Inc. has announced that its board of directors and majority shareholders have approved certain corporate actions, including the adoption of an Amended and Restated Certificate of Incorporation. The company stated that these changes were duly adopted in accordance with its governing documents and Delaware law. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rani Therapeutics Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-297587), on November 25, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
